|Available protein structures:Pfam|
|Available protein structures:|
|PDB||, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
ALP has the physiological role of dephosphorylating compounds.
This enzyme is heat stable and has its maximum activity at high pH.
In humans, it is found in many forms depending on its origin within the body – it plays an integral role in metabolism within the liver and development within the skeleton.
The level of alkaline phosphatase in the blood is checked through the ALP test, which is often part of routine blood tests.
The levels of this enzyme in the blood depend on factors such as age, sex, or blood type.
Blood levels of alkaline phosphatase also increase by two to four times during pregnancy.
This is a result of additional alkaline phosphatase produced by the placenta.
Additionally, abnormal levels of alkaline phosphatase in the blood could indicate issues relating to the liver, gall bladder or bones.
Kidney tumors and infections as well as malnutrition have also shown abnormal level of alkaline phosphatase in blood.
Alkaline phosphatase levels in a cell can be measured through a process called "The scoring method".
A blood smear is usually taken and stained to categorize each leukocyte into specific "leukocyte alkaline phosphatase indices".
This marker is designed to distinguish leukocytes and determine different enzyme activity from each sample's extent of staining.
In Gram-negative bacteria, such as Escherichia coli (E. coli), alkaline phosphatase is located in the periplasmic space, external to the inner cell membrane and within the peptidoglycan portion of the cell wall.
This characteristic of the enzyme is uncommon to many other proteins.
The precise structure and function of the four isozymes (Int in E.coli) are solely geared to supply a source of inorganic phosphate when the environment lacks this metabolite.
The four enzymes are dependent upon the location of the tissue expression.
The four sites of tissue expression are the Intestinal AlP, Placental ALP, Germ Cell ALP and Liver/Bone/Kidney ALP.
The inorganic phosphates produced by these isozymes are then bound to carrier proteins which deliver the inorganic phosphates to a specific high-affinity transport system, known as the Pst system, which transports phosphate across the cytoplasmic membrane.
While the outer membrane of E. coli contains porins that are permeable to phosphorylated compounds, the inner membrane does not.
Then, an issue arises in how to transport such compounds across the inner membrane and into the cytosol.
Surely, with the strong anionic charge of phosphate groups along with the remainder of the compound they are very much immiscible in the nonpolar region of the bilayer.
The solution arises in cleaving the phosphate group away from the compound via ALP.
In effect, along with the concomitant compound the phosphate was bound to, this enzyme yields pure inorganic phosphate which can be ultimately targeted by the phosphate-specific transport system (Pst system) for translocation into the cytosol.
As such, the main purpose of dephosphorylation by alkaline phosphatase is to increase the rate of diffusion of the molecules into the cells and inhibit them from diffusing out.
Alkaline phosphatase is a zinc-containing dimeric enzyme with the MW: 86,000 Da, each subunit containing 429 amino acids with four cysteine residues linking the two subunits.
Alkaline phosphatase contains four Zn ions and two Mg ions, with Zn occupying active sites A and B, and Mg occupying site C, so the fully active native alkaline phosphatase is referred to as (ZnAZnBMgC)2 enzyme.
The mechanism of action of alkaline phosphatase involves the geometric coordination of the substrate between the Zn ions in the active sites, whereas the Mg site doesn't appear to be close enough to directly partake in the hydrolysis mechanism, however, it may contribute to the shape of the electrostatic potential around the active center.
Alkaline phosphatase has a Km of 8.4 x 10.
Alkaline phosphatase in E. coli is uncommonly soluble and active within elevated temperature conditions such as 80 °C.
Due to the kinetic energy induced by this temperature the weak hydrogen bonds and hydrophobic interactions of common proteins become degraded and therefore coalesce and precipitate.
However, upon dimerization of ALP the bonds maintaining its secondary and tertiary structures are effectively buried such that they are not affected as much at this temperature.
Furthermore, even at more elevated temperatures such as 90 °C ALP has the uncommon characteristic of reverse denaturation.
Due to this, while ALP ultimately denatures at about 90 °C it has the added ability to accurately reform its bonds and return to its original structure and function once cooled back down.
Alkaline phosphatase in E. coli is located in the periplasmic space and can thus be released using techniques that weaken the cell wall and release the protein.
Due to the location of the enzyme, and the protein layout of the enzyme, the enzyme is in solution with a smaller amount of proteins than there are in another portion of the cell.
The proteins' heat stability can also be taken advantage of when isolating this enzyme (through heat denaturation).
In addition, alkaline phosphatase can be assayed using p-Nitrophenyl phosphate.
A reaction where alkaline phosphatase dephosphorylates the non-specific substrate, p-Nitrophenyl phosphate in order to produce p-Nitrophenol(PNP) and inorganic phosphate.
PNP's yellow color, and its λmax at 410 allows spectrophotometry to determine important information about enzymatic activity.
The optimal pH for the activity of the E. coli enzyme is 8.0 while the bovine enzyme optimum pH is slightly higher at 8.5.
Alkaline phosphatase accounts for 6% of all proteins in derepressed cells.
When multiple copies of a polypeptide encoded by a gene form an aggregate, this protein structure is referred to as a multimer.
When a multimer is formed from polypeptides produced by two different mutant alleles of a particular gene, the mixed multimer may exhibit greater functional activity than the unmixed multimers formed by each of the mutants alone.
In such a case, the phenomenon is referred to as intragenic complementation.
E. coli alkaline phosphatase, a dimer enzyme, exhibits intragenic complementation.
When particular mutant versions of alkaline phosphatase were combined, the heterodimeric enzymes formed as a result exhibited a higher level of activity than would be expected based on the relative activities of the parental enzymes.
These findings indicated that the dimer structure of E.coli alkaline phosphatase allows cooperative interactions between the constituent monomers that can generate a more functional form of the holoenzyme.
Use in research
By changing the amino acids of the wild-type alkaline phosphatase enzyme produced by Escherichia coli, a mutant alkaline phosphatase is created which not only has a 36-fold increase in enzyme activity, but also retains thermal stability.
Typical uses in the lab for alkaline phosphatases include removing phosphate monoesters to prevent self-ligation, which is undesirable during plasmid DNA cloning.
Common alkaline phosphatases used in research include:
- Shrimp alkaline phosphatase (SAP), from a species of Arctic shrimp (Pandalus borealis). This phosphatase is easily inactivated by heat, a useful feature in some applications.
- Calf-intestinal alkaline phosphatase (CIP)
- Placental alkaline phosphatase (PLAP) and its C terminally truncated version that lacks the last 24 amino acids (constituting the domain that targets for GPI membrane anchoring) – the secreted alkaline phosphatase (SEAP). It presents certain characteristics like heat stability, substrate specificity, and resistance to chemical inactivation.
- Human-intestinal alkaline phosphatase. The human body has multiple types of alkaline phosphatase present, which are determined by a minimum of three gene loci. Each one of these three loci controls a different kind of alkaline phosphatase isozyme. However, the development of this enzyme can be strictly regulated by other factors such as thermostability, electrophoresis, inhibition, or immunology.
Human-intestinal ALPase shows around 80% homology with bovine intestinal ALPase, which holds true their shared evolutionary origins.
That same bovine enzyme has more than 70% homology with human placental enzyme.
However, the human intestinal enzyme and the placental enzyme only share 20% homology despite their structural similarities.
Removing these phosphates prevents the DNA from ligating (the 5' end attaching to the 3' end), thereby keeping DNA molecules linear until the next step of the process for which they are being prepared; also, removal of the phosphate groups allows radiolabeling (replacement by radioactive phosphate groups) in order to measure the presence of the labeled DNA through further steps in the process or experiment.
For these purposes, the alkaline phosphatase from shrimp is the most useful, as it is the easiest to inactivate once it has done its job.
Another important use of alkaline phosphatase is as a label for enzyme immunoassays.
Undifferentiated pluripotent stem cells have elevated levels of alkaline phosphatase on their cell membrane, therefore alkaline phosphatase staining is used to detect these cells and to test pluripotency (i.e., embryonic stem cells or embryonal carcinoma cells).
There is a positive correlation between serum bone alkaline phosphatase (B-ALP) levels and bone formation in humans, although its use as a biomarker in clinical practice is not recommended.
Current researchers are looking into the increase of tumor necrosis factor-α and its direct effect on the expression of alkaline phosphatase in vascular smooth muscle cells as well as how alkaline phosphatase (AP) affects the inflammatory responses and may play a direct role in preventing organ damage.
- Alkaline phosphatase (AP) affects the inflammatory responses in patients with Chronic kidney disease and is directly associated with Erythropoiesis stimulating agent resistant anemia.
- Intestinal alkaline phosphatase (IAP) and the mechanism it uses to regulate pH and ATP hydrolysis in rat duodenum.
- Testing the effectiveness of the inhibitor and its impact on IAP in acute intestinal inflammation as well as explore the molecular mechanisms of IAP in "ameliorating intestinal permeability."
Main article: Pasteurization § Verification
Alkaline phosphatase is commonly used in the dairy industry as an indicator of successful pasteurization.
Therefore, ALP presence is ideal for indicating failed pasteurization.
Pasteurization verification is typically performed by measuring the fluorescence of a solution which becomes fluorescent when exposed to active ALP.
Fluorimetry assays are required by milk producers in the UK to prove alkaline phosphatase has been denatured, as p-Nitrophenylphosphate tests are not considered accurate enough to meet health standards.
Alternatively the colour change of a para-Nitrophenylphosphate substrate in a buffered solution (Aschaffenburg Mullen Test) can be used.
Raw milk would typically produce a yellow colouration within a couple of minutes, whereas properly pasteurised milk should show no change.
There are exceptions to this, as in the case of heat-stable alkaline phophatases produced by some bacteria, but these bacteria should not be present in milk.
All mammalian alkaline phosphatase isoenzymes except placental (PALP and SEAP) are inhibited by homoarginine, and, in similar manner, all except the intestinal and placental ones are blocked by levamisole.
Phosphate is another inhibitor which competitively inhibits alkaline phosphatase.
Another known example of an alkaline phosphatase inhibitor is [(4-Nitrophenyl)methyl]phosphonic acid.
In metal contaminated soil, alkaline phosphatase are inhibited by Cd (Cadmium).
In addition, temperature enhances the inhibition of Cd on ALP activity, which is shown in the increasing values of Km.
During childhood the majority of alkaline phosphatase are of skeletal origin.
Humans and most other mammals contain the following alkaline phosphatase isozymes:
- ALPI – intestinal (molecular weight of 150 kDa)
- ALPL – tissue-nonspecific (expressed mainly in liver, bone, and kidney)
- ALPP – placental (Regan isozyme)
- ALPG – germ cell
Four genes encode the four isozymes.
Intestinal alkaline phosphatase
Intestinal alkaline phosphatase is secreted by enterocytes, and seems to play a pivotal role in intestinal homeostasis and protection as well as in mediation of inflammation via repression of the downstream Toll-like receptor (TLR)-4-dependent and MyD88-dependent inflammatory cascade.
It dephosphorylates toxic/inflammatory microbial ligands like lipopolysaccharides, unmethylated cytosine-guanine dinucleotides, flagellin, and extracellular nucleotides such as uridine diphosphate or ATP.
Thus, altered IAP expression has been implicated in chronic inflammatory diseases such as inflammatory bowel disease (IBD).
It also seems to regulate lipid absorption and bicarbonate secretion in the duodenal mucosa, which regulates the surface pH.
In cancer cells
Studies show that the alkaline phosphatase protein found in cancer cells is similar to that found in nonmalignant body tissues and that the protein originates from the same gene in both.
One study compared the enzymes of liver metastases of giant-cell lung carcinoma and nonmalignant placental cells.
The two were similar in NH2-terminal sequence, peptide map, subunit molecular weight, and isoelectronic point.
In a different study in which scientists examined alkaline phosphatase protein presence in a human colon cancer cell line, also known as HT-29, results showed that the enzyme activity was similar to that of the non-malignant intestinal type.
However, this study revealed that without the influence of sodium butyrate, alkaline phosphatase activity is fairly low in cancer cells.
A study based on sodium butyrate effects on cancer cells conveys that it has an effect on androgen receptor co-regulator expression, transcription activity, and also on histone acetylation in cancer cells.
This explains why the addition of sodium butyrate show increased activity of alkaline phosphatase in the cancer cells of the human colon.
In addition, this further supports the theory that alkaline phosphatase enzyme activity is actually present in cancer cells.
In another study, choriocarcinoma cells were grown in the presence of 5-bromo-2’-deoxyuridine (BrdUrd) and results conveyed a 30- to 40- fold increase in alkaline phosphatase activity.
This procedure of enhancing the activity of the enzyme is known as enzyme induction.
The evidence shows that there is in fact activity of alkaline phosphatase in tumor cells, but it is minimal and needs to be enhanced.
Results from this study further indicate that activities of this enzyme vary among the different choriocarcinoma cell lines and that the activity of the alkaline phosphatase protein in these cells is lower than in the non-malignant placenta cells.
but levels are significantly higher in children and pregnant women.
Blood tests should always be interpreted using the reference range from the laboratory that performed the test.
High ALP levels can occur if the bile ducts are obstructed.
High levels of ALP in prostate cancer patients is associated with a significant decrease in survival.
Levels are also elevated in people with untreated coeliac disease.
Lowered levels of ALP are less common than elevated levels.
The source of elevated ALP levels can be deduced by obtaining serum levels of gamma glutamyltransferase (GGT).
Concomitant increases of ALP with GGT should raise the suspicion of hepatobiliary disease.
Some diseases do not affect the levels of alkaline phosphatase, for example, hepatitis C. A high level of this enzyme does not reflect any damage in the liver, even though high alkaline phosphatase levels may result from a blockage of flow in the biliary tract or an increase in the pressure of the liver.
Main article: Elevated alkaline phosphatase
Skelphosphatase (which is localized in osteoblasts and extracellular layers of newly synthesized matrix) is released into circulation by a yet unclear mechanism.
- Biliary obstruction
- Bone conditions
- Osteoblastic bone tumors
- Acute cholecystitis
- Leukemoid reaction
- Paget's disease
- Myocardial infarction
The following conditions or diseases may lead to reduced levels of alkaline phosphatase:
- Hypophosphatasia, an autosomal recessive disease
- Postmenopausal women receiving estrogen therapy because of aging
- Men with recent heart surgery, malnutrition, magnesium deficiency, or severe anemia
- Children with achondroplasia and congenital iodine deficiency
- Children after a severe episode of enteritis
- Pernicious anemia
- Aplastic anemia
- Wilson's disease
In addition, oral contraceptives have been demonstrated to reduce alkaline phosphatase.
Measuring alkaline phosphatase (along with prostate specific antigen) during, and after six months of hormone treated metastatic prostate cancer was shown to predict the survival of patients.
Leukocyte alkaline phosphatase
Leukocyte alkaline phosphatase (LAP) is found within mature white blood cells.
White blood cell levels of LAP can help in the diagnosis of certain conditions.
- Higher levels are seen in the physiological response, the leukemoid reaction, and in pathologies that include mature white blood cells, such as polycythemia vera (PV), essential thrombocytosis (ET), and in primary myelofibrosis (PM).
- Lower levels are found in pathologies that involve undeveloped leukocytes, such as chronic myelogenous leukemia (CML), paroxysmal nocturnal hemoglobinuria (PNH) and acute myelogenous leukaemia (AML).
Structure and properties
Alkaline phosphatase is homodimeric enzyme, meaning it is formed with two molecules.
Three metal ions, two Zn and one Mg, are contained in the catalytic sites, and both types are crucial for enzymatic activity to occur.
The enzymes catalyze the hydrolysis of monoesters in phosphoric acid which can additionally catalyze a transphosphorylation reaction with large concentrations of phosphate acceptors.
While the main features of the catalytic mechanism and activity are conserved between mammalian and bacterial alkaline phosphate, mammalian alkaline phosphatase has a higher specific activity and Km values thus a lower affinity, more alkaline pH optimum, lower heat stability, and are typically membrane bound and are inhibited by l-amino acids and peptides via a means of uncompetitive mechanism.
These properties noticeably differ between different mammalian alkaline phosphatase isozymes and therefore showcase a difference in in vivo functions.
Alkaline phosphatase has homology in a large number of other enzymes and composes part of a superfamily of enzymes with several overlapping catalytic aspects and substrate traits.
This explains why most salient structural features of mammalian alkaline are the way they are and reference their substrate specificity and homology to other members of the nucleoside pyrophosphatase/phosphodiesterase family of isozyme.
Research has shown a relationship between members of the alkaline phosphatase family with aryl sulfatases.
The similarities in structure indicate that these two enzyme families came from a common ancestor.
Further analysis has linked alkaline phosphates and aryl sulfatases to a larger superfamily.
Some of the common genes found in this superfamily, are ones that encode phosphodiesterases as well as autotoxin.
Credits to the contents of this page go to the authors of the corresponding Wikipedia page: en.wikipedia.org/wiki/Alkaline phosphatase.